- Conditions: Pain; Otitis Media
Interventions: Drug: benzocaine; Drug: placebo
Sponsors: Arbor Pharmaceuticals, Inc.; Arbor Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Conditions: Acute Lymphocytic Leukemia; Acute Myelogenous Leukemia; Burkitt's Lymphoma; Follicular Lymphoma; Hodgkin Lymphoma; Mantle Cell Lymphoma
Interventions: Drug: Biological/Vaccine: Haploidentical BMT; Drug: Double Cord Blood Transplantation
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI); National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials Network
Not yet recruiting - verified May 2012 - Conditions: Cancer; Sickle Cell Disease
Interventions: Other: Text messaging; Other: Questionnaire; Other: Interviews
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital; San Diego State University
Recruiting - verified April 2012 - Condition: Tobacco Abuse Cigarette
Interventions: Behavioral: Quitline facilitation intervention; Behavioral: Brief stop-smoking intervention
Sponsors: Mayo Clinic; Mayo Clinic
Not yet recruiting - verified April 2012 - Conditions: Heart Failure; Respiratory Failure
Interventions: Drug: Insulin; Drug: Insulin
Sponsors: Children's Hospital Boston; Children's Hospital Boston; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Conditions: Fatigue; Multiple Sclerosis; Sleep Apnea
Interventions: Device: Auto-titration CPAP; Device: Sham-CPAP
Sponsors: Northwestern University; Northwestern University
Recruiting - verified March 2012 - Conditions: Cerebrovascular Disorders; Deglutition Disorders
Intervention: Behavioral: Establishing Validity and Reliability
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified March 2012 - Condition: Opiate Dependence
Interventions: Drug: Vivitrol; Behavioral: Employment based opiate abstinence reinforcement; Other: Usual Care Control
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified March 2012 - Condition: Psoriasis
Interventions: Drug: Ustekinumab 45 mg; Drug: Ustekinumab 90 mg; Drug: Placebo
Sponsors: Janssen Biotech, Inc.; Janssen Biotech, Inc.
Recruiting - verified May 2012 - Conditions: Mild Cognitive Impairment; Cognitive Disorders
Intervention: Behavioral: 5-month aerobic exercise intervention
Sponsors: Wake Forest University; Wake Forest University
Recruiting - verified March 2012 - Condition: Postoperative Pain.
Interventions: Drug: Subpleural pain catheter with infusion of 0.125% bupivacaine; Drug: Standard acute pain management
Sponsors: Inova Health Care Services; Inova Health Care Services
Not yet recruiting - verified February 2012 - Conditions: Methamphetamine Dependence; Methamphetamine Abuse; Substance Abuse
Interventions: Drug: Placebo; Drug: Varenicline; Drug: Varenicline
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Condition: Chronic Ankle Instability
Interventions: Other: Ankle Joint Mobilization; Other: Foot Massage; Other: Calf Stretching
Sponsors: University of Kentucky; University of Kentucky; University of North Carolina, Charlotte; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified February 2012 - Conditions: Restless Legs Syndrome; End-Stage Renal Disease
Interventions: Drug: Rotigotine; Drug: Placebo
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Chronic Headaches
Intervention: Behavioral: Behavioral Treatment for Chronic Headache- Exercise Version
Sponsors: University of Mississippi Medical Center; University of Mississippi Medical Center
Recruiting - verified November 2011 - Conditions: Postmenopausal Disorder; Blood Pressure; Over Weight
Interventions: Behavioral: Basic Intervention; Behavioral: Enhanced Pedometry; Behavioral: Control Group
Sponsors: Pennington Biomedical Research Center; Pennington Biomedical Research Center; American Heart Association
Recruiting - verified January 2012 - Condition: Convergence Insufficiency
Interventions: Other: Active home-based computer vergence/accommodative therapy; Procedure: Near target push-ups; Other: Placebo home-based computer vergence/accommodative therapy; Procedure: Placebo yoked prism flippers
Sponsors: Jaeb Center for Health Research; Jaeb Center for Health Research; National Eye Institute (NEI)
Not yet recruiting - verified January 2012 - Condition: Lymphedema
Interventions: Behavioral: Exercise Intervention; Behavioral: Weight Loss Intervention
Sponsors: University of Pennsylvania; University of Pennsylvania
Recruiting - verified January 2012 - Condition: Obesity
Intervention: Procedure: Laparoscopic Greater Curvature Plication
Sponsors: Singh, Kuldeep, M.D., P.A.; Singh, Kuldeep, M.D., P.A.
Recruiting - verified March 2012 - Conditions: Pain; Total Knee Arthroplasty
Interventions: Drug: Dexamethasone; Drug: Ropivacaine
Sponsors: University of New Mexico; University of New Mexico
Not yet recruiting - verified April 2012 - Condition: Cognitive Impairment, no Dementia (CIND)
Interventions: Behavioral: Aerobic Exercise; Behavioral: DASH diet; Other: Health education control
Sponsors: Duke University; Duke University
Recruiting - verified April 2012 - Portable Mantram Meditation for Veterans With Military Related Post Traumatic Stress Syndrome (PTSD)Conditions: Veterans; Stress Disorders, Post-Traumatic
Interventions: Behavioral: Mantram Repetition Program (MRP); Behavioral: Present Centered Group Therapy (PCGT)
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Insomnia
Interventions: Drug: Dexmedetomidine; Drug: Zolpidem; Drug: Oral Placebo; Drug: Normal Saline placebo.
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified December 2011 - Condition: Huntington's Disease
Intervention: Drug: SEN0014196
Sponsors: Siena Biotech S.p.A.; Siena Biotech S.p.A.
Recruiting - verified March 2012 - Condition: Migraine Headache
Intervention: Procedure: Acupuncture
Sponsors: National University of Health Sciences; National University of Health Sciences
Recruiting - verified November 2011 - Condition: Chronic Kidney Disease
Interventions: Other: K2CG chewing gum (20mg chitosan); Other: K2CG chewing gum (60mg chitosan); Other: No intervention
Sponsors: Denver Nephrologists, P.C.; Denver Nephrologists, P.C.; CM&D Pharma Limited
Recruiting - verified November 2011 - Condition: Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: AZD3480
Sponsors: Targacept Inc.; Targacept Inc.
Recruiting - verified May 2012 - Conditions: Transfusion Reactions; Post Cardiac Surgery
Interventions: Other: Blood transfusion; Other: Blood transfusion
Sponsors: Hackensack University Medical Center; Hackensack University Medical Center
Not yet recruiting - verified October 2011 - Conditions: Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenic Purpura
Interventions: Drug: romiplostim; Drug: Placebo
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Conditions: Renal Failure; Tremors
Interventions: Drug: Prograf; Drug: LCP-Tacro
Sponsors: Veloxis Pharmaceuticals; Veloxis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Obesity
Interventions: Behavioral: Go! Foods for You without Weekly MA Support.; Behavioral: Go! Foods for You with Weekly MA Support.
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Not yet recruiting - verified February 2012 - Condition: Overweight and Obesity
Interventions: Behavioral: Sleep Duration; Behavioral: Behavioral: No change in sleep
Sponsors: The Miriam Hospital; The Miriam Hospital
Recruiting - verified October 2011 - Conditions: Major Depressive Disorder; Bipolar Disorder
Interventions: Behavioral: Wake Therapy; Device: lightbox; Drug: Lithium Carbonate; Drug: Armodafinil
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Recruiting - verified April 2012 - Conditions: Hypertension; Diabetes Mellitus
Intervention: Other: Self-monitoring-nurse-primary care provider feedback loop
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester; Reliant Medical Group; University of Massachusetts, Amherst
Recruiting - verified February 2012 - Conditions: Blunt Trauma; Penetrating Wound; Hemorrhagic Shock
Interventions: Drug: Sodium Chloride 0.9% Injection; Drug: Sodium Chloride 0.9% Injection
Sponsors: University of Washington; University of Washington; National Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Conditions: Diabetes; Weight Loss; Physical Function; Cognitive Function
Interventions: Behavioral: Lifestyle intervention; Behavioral: Diabetes Support Education
Sponsors: Wake Forest University; Wake Forest University; Pennington Biomedical Research Center; University of Colorado, Denver; University of Tennessee; University of Pittsburgh
Recruiting - verified September 2011 - Conditions: Bipolar Disorder; Psychosis
Interventions: Behavioral: BrainWorks; Behavioral: Computer Control
Sponsors: Mclean Hospital; Mclean Hospital; National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Conditions: Acute Ischemic Stroke; Diabetes; Hyperglycemia
Interventions: Drug: IV insulin to maintain target glucose concentration of 80-130 mg/dL; Drug: Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
Sponsors: University of Virginia; University of Virginia; Neurological Emergencies Treatment Trials Network (NETT); Medical University of South Carolina; Medical Automation Systems, an Alere Company; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified May 2012 - Condition: Diabetes
Intervention: Device: Technology-Assisted Case Management (TACM with the FORA 2-in-1 Telehealth System)
Sponsors: Medical University of South Carolina; Medical University of South Carolina; Department of Defense
Recruiting - verified April 2011 - Condition: Physical Activity
Interventions: Behavioral: Pedal@Work Worksite Wellness; Behavioral: Pedal@Work
Sponsors: East Carolina University; East Carolina University
Recruiting - verified June 2011 - Condition: Obesity
Intervention: Behavioral: Interventions
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified March 2012 - Conditions: Kidney Transplantation; Medication Adherence
Interventions: Device: Medminder adherence monitoring; Behavioral: Action-focused problem-solving; Device: Medminder dosage reminders
Sponsors: McGill University Health Center; McGill University Health Center; Children's Hospital of Philadelphia; Children's Hospital Medical Center, Cincinnati; Seattle Children's Hospital; University of Florida; Children's & Women's Health Centre of British Columbia; The Hospital for Sick Children
Recruiting - verified March 2012 - Condition: Healthy
Interventions: Drug: CW 002; Drug: CW 002; Drug: CW 002
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified June 2011 - Condition: Acute Kidney Injury
Interventions: Drug: ATG; Drug: Rituximab; Drug: Methylprednisolone; Drug: Diphenhydramine; Drug: Acetaminophen; Drug: Tacrolimus; Drug: Sirolimus; Drug: Hydrocortisone; Drug: Prednisone
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN)
Recruiting - verified August 2011 - Conditions: Chronic Migraine; Insomnia
Interventions: Behavioral: Stimulus Control and Sleep Restriction; Behavioral: Lifestyle Modification
Sponsors: University of Mississippi, Oxford; University of Mississippi, Oxford; Migraine Research Foundation; The Oxford Neurology Clinic
Recruiting - verified September 2011 - Condition: Anorexia Nervosa
Interventions: Drug: RhIGF-1 with transdermal 17-beta estradiol; Drug: Placebo and transdermal 17-beta estradiol
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; The Hospital for Sick Children
Recruiting - verified February 2012 - Conditions: Insulin Resistance; Obesity
Interventions: Behavioral: weight loss; Behavioral: weight maintenance
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified August 2011 - Condition: Transient Tachypnea of the Newborn
Interventions: Other: High Flow Nasal Cannula; Other: Bubble Nasal CPAP
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine
Recruiting - verified January 2012 - Conditions: Exercise; Energy; Body Weight
Intervention:
Sponsors: Pennington Biomedical Research Center; Pennington Biomedical Research Center
Recruiting - verified January 2012 - Condition: Sedation
Interventions: Procedure: 1:1 ketamine-propofol mixture sedation; Procedure: Propofol Sedation
Sponsors: University of Utah; University of Utah
Recruiting - verified August 2011 - Condition: Sleep Disorders
Interventions: Other: Normal saline infusion; Drug: Dexmedetomidine; Drug: Propofol
Sponsors: University of California, San Francisco; University of California, San Francisco; Masimo Labs
Recruiting - verified May 2012 - Condition: Health Behavior
Interventions: Behavioral: Sequential MBC Condition; Behavioral: Simultaneous MBC Condition; Behavioral: Stress Management
Sponsors: Northwestern University; Northwestern University; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified July 2011 - Conditions: Atrial Fibrillation; Arrhythmias, Cardiac
Intervention:
Sponsors: University of California, San Diego; University of California, San Diego; National Institutes of Health (NIH)
Recruiting - verified November 2011 - Condition: Respiratory Distress Syndrome, Newborn
Interventions: Procedure: Conventional Pressure Controlled SIMV; Other: Mid-frequency Ventilation
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Recruiting - verified February 2012 - Condition: Lymphedema
Interventions: Device: Flexitouch System; Device: Hydroven FPR
Sponsors: Centre for Research & Implementation of Clinical Practice; Centre for Research & Implementation of Clinical Practice; Tactile Systems Technology Inc.
Recruiting - verified August 2011 - Condition: Hypertension
Intervention: Other: Favor one of two thiazides for new prescriptions & attempt target dose
Sponsors: VA Pharmacy Benefits Management Strategic Healthcare Group; VA Pharmacy Benefits Management Strategic Healthcare Group
Recruiting - verified September 2011 - Condition: Morbid Obesity
Intervention: Procedure: Laparoscopic Gastric Plication
Sponsors: Ponce, Jaime, M.D.; Ponce, Jaime, M.D.
Recruiting - verified May 2012 - Condition: Hematologic Malignancies
Interventions: Other: Fludarabine, Cytoxan, TBI, Sirolimus; Other: Fludarabine, Cytoxan, TBI, Sirolimus + MMF; Other: Fludarabine, Cytoxan, TBI, Tacrolimus + MMF
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center
Recruiting - verified January 2012 - Conditions: Deep Brain Stimulation (DBS); Blood Flow; Brain Oxygenation
Interventions: Drug: dexmedetomidine; Drug: propofol
Sponsors: Outcomes Research Consortium; Outcomes Research Consortium
Recruiting - verified June 2011 - Condition: High-risk, Non-cardiovascular Surgeries
Intervention: Drug: Esmolol
Sponsors: Duke University; Duke University; Baxter Healthcare Corporation
Recruiting - verified December 2011 - Condition: Lung Cancer
Interventions: Other: General-epidural anesthesia and analgesia; Other: Balanced general anesthesia and postoperative opioids
Sponsors: Outcomes Research Consortium; Outcomes Research Consortium
Recruiting - verified August 2011 - Conditions: Atrial Fibrillation; Stroke
Interventions: Device: WATCHMAN Device; Drug: Warfarin
Sponsors: Atritech; Atritech
Recruiting - verified April 2012 - Condition: Intracerebral Hemorrhage
Intervention: Drug: Nicardipine hydrochloride
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; Medical University of South Carolina; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2012 - Conditions: Spinal Muscular Atrophy; Neuromuscular Disease
Intervention: Other: Exercise
Sponsors: Columbia University; Columbia University
Recruiting - verified October 2011 - Condition: HIV Infection
Interventions: Behavioral: Linkage-to-Care Component: Financial Incentive (FI); Behavioral: Linkage-to-Care Component: Standard of Care (SOC); Behavioral: Viral Suppression Component: FI; Behavioral: Viral Suppression Component: SOC; Behavioral: Prevention for Positives Component: Counseling and SOC; Behavioral: Prevention for Positives Component: SOC
Sponsors: HIV Prevention Trials Network; HIV Prevention Trials Network; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2012 - Conditions: Cancer; Leukemia; Lymphoma
Intervention: Drug: Sirolimus and Methotrexate
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia; The Leukemia and Lymphoma Society
Recruiting - verified November 2011 - Condition: Fibromyalgia
Interventions: Drug: Milnacipran; Procedure: Skin biopsy
Sponsors: Albany Medical College; Albany Medical College; Forest Laboratories
Recruiting - verified December 2010 - Condition: Head and Neck Cancer
Interventions: Other: radiation combined with weekly carboplatin; Procedure: conservation surgery
Sponsors: Southern Illinois University; Southern Illinois University
Recruiting - verified March 2012 - Condition: Cystic Fibrosis
Interventions: Drug: Sildenafil; Drug: Placebo
Sponsors: National Jewish Health; National Jewish Health
Not yet recruiting - verified July 2011 - Condition: Down Syndrome
Interventions: Drug: Rivastigmine; Other: Liquid Placebo
Sponsors: Duke University; Duke University; Taishoff Family Foundation
Recruiting - verified March 2012 - Conditions: Overweight; Obesity; Weight Loss Maintenance
Interventions: Behavioral: Behavior Therapy; Dietary Supplement: Meal Replacements; Behavioral: Nutritrol
Sponsors: Drexel University; Drexel University; University of Pennsylvania
Recruiting - verified November 2011 - Condition: Hypertension
Intervention: Behavioral: Motivational interviewing (MINT-TLC)
Sponsors: New York University School of Medicine; New York University School of Medicine; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Condition: Pancreatic Cancer
Interventions: Other: restrictive perioperative fluid management; Other: Liberal perioperative fluid management
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified May 2012 - Conditions: Diabetes; Obesity; Weight Gain
Intervention: Behavioral: Behavioral Weight Loss Program
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified December 2011 - Conditions: Aortic Aneurysm; Aortic Disease
Intervention: Drug: clevidipine.
Sponsors: The Methodist Hospital System; The Methodist Hospital System; The Medicines Company
Recruiting - verified July 2011 - Condition: Epidermolysis Bullosa
Interventions: Drug: Cyclophosphamide; Drug: Fludarabine; Drug: Anti-thymocyte globulin; Drug: Cyclosporine A; Drug: Mycophenolate mofetil; Procedure: Hematopoietic stem cell transplant; Procedure: Mesenchymal stem cell transplant; Radiation: Total body irradiation
Sponsors: Masonic Cancer Center, University of Minnesota; Masonic Cancer Center, University of Minnesota
Recruiting - verified May 2012 - Condition: Immune Thrombocytopenic Purpura
Interventions: Drug: Dexamethasone USP Micronized; Drug: Prednisone
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Conditions: Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism; Thromboembolism; Venous Thrombosis
Interventions: Drug: edoxaban tosylate(DU-176b); Drug: low molecular weight heparin/unfractionated heparin; Drug: warfarin
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified February 2012 - Condition: Muscle Loss
Interventions: Dietary Supplement: Leucine; Dietary Supplement: Leucine
Sponsors: The University of Texas, Galveston; The University of Texas, Galveston; National Space Biomedical Research Institute
Recruiting - verified December 2011 - Condition: Kidney Transplant
Interventions: Drug: Tacrolimus; Drug: Sirolimus (Rapamune, Rapamycin); Drug: Mycophenolate Mofetil + Prednisone
Sponsors: Mayo Clinic; Mayo Clinic; Wyeth is now a wholly owned subsidiary of Pfizer
Recruiting - verified December 2011 - Condition: Glioblastoma Multiforme
Interventions: Device: NovoTTF-100A device; Drug: Temozolomide
Sponsors: NovoCure Ltd.; NovoCure Ltd.
Recruiting - verified March 2012 - Condition: Lymphoma, Non-Hodgkin
Intervention: Biological: Hematopoietic Stem Cell Transplant
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant Clinical Trials Network; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Conditions: Insomnia; Blindness; Daytime Sleepiness
Interventions: Drug: Melatonin; Behavioral: Regular Sleep Schedule; Behavioral: Light
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified July 2011 - Conditions: Glial Cell Tumors; Malignant Gliomas; Glioblastoma Multiforme; Anaplastic Astrocytoma; Gliomatosis Cerebri; Gliosarcoma; Brainstem Glioma
Interventions: Drug: Valproic acid; Drug: Bevacizumab; Radiation: Radiation therapy
Sponsors: Baylor College of Medicine; Baylor College of Medicine
Recruiting - verified February 2012 - Conditions: Prematurity; Intraventricular Hemorrhage; Hydrocephalus
Interventions: Procedure: Removal of CSF through ventricular access device; Procedure: Removal of CSF through a ventricular access device
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified August 2011 - Conditions: Systemic Lupus Erythematosus; Systemic Sclerosis
Intervention: Procedure: Nonmyeloablative allogeneic stem cell transplant
Sponsors: Duke University; Duke University
Recruiting - verified February 2012 - Condition: Congenital Hyperinsulinism
Intervention: Drug: Exendin-(9-39)
Sponsors: Children's Hospital of Philadelphia; Diva De Leon
Recruiting - verified February 2012 - Condition: Traumatic Brain Injury
Interventions: Drug: Recombinant human Growth Hormone; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; Baylor Health Care System
Recruiting - verified May 2012 - Conditions: Candidemia; Candidiasis
Interventions: Drug: anidulafungin; Drug: fluconazole
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Heart Failure
Interventions: Device: Medtronic CRT (InSync or Concerto); Device: Medtronic CRT (Insync or Concerto)
Sponsors: Columbia University; Columbia University; Medtronic
Recruiting - verified October 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: Supplemental oxygen therapy
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI); Centers for Medicare and Medicaid Services
Recruiting - verified April 2012 - Conditions: Intraventricular Hemorrhage; Autoregulation
Interventions: Device: Hypercapnia; Other: Normocapnia
Sponsors: University of Arkansas; University of Arkansas; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified January 2012 - Condition: Ulcerative Colitis
Intervention: Drug: mesalamine
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Shire Development LLC
Recruiting - verified December 2011 - Conditions: Neurofibromatosis Type 1; Reading Disabilities
Interventions: Behavioral: Tutoring Program I; Behavioral: Tutoring Program II
Sponsors: Vanderbilt University; Vanderbilt University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified June 2011 - Conditions: Leukemia; Hodgkin Lymphoma; Non Hodgkin Lymphoma; Myeloproliferative Disorders
Interventions: Drug: Ara C; Drug: Cyclophosphamide; Drug: MESNA; Procedure: TBI; Biological: Campath-1h; Procedure: Stem Cell Infusion; Drug: Tacrolimus; Drug: Methotrexate
Sponsors: Baylor College of Medicine; Baylor College of Medicine
Recruiting - verified April 2012 - Conditions: Leukemia; Cancer; Lymphoma
Interventions: Drug: Ara-C; Drug: Cytoxan; Drug: Mesna; Radiation: TBI Fraction; Procedure: Stem Cell Infusion; Drug: Methotrexate; Drug: Tacrolimus
Sponsors: Baylor College of Medicine; Baylor College of Medicine; Texas Children's Hospital
Recruiting - verified April 2012 - Conditions: Preeclampsia; Hypotension
Interventions: Drug: Ephedrine; Drug: Phenylephrine
Sponsors: Northwestern University; Northwestern University
Recruiting - verified January 2012 - Conditions: Cardiopulmonary Bypass; Heart Defects, Congenital; Hyperglycemia
Interventions: Drug: Insulin; Other: Usual Care
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Condition: Menstrual Irregularity
Intervention: Behavioral: Increased calorie intake
Sponsors: Penn State University; Penn State University; Department of Defense
Recruiting - verified August 2010 - Condition: Hemophilia A
Interventions: Drug: Recombinant Protein-Free Factor VIII (rAHF-PFM); Drug: Recombinant Protein-Free Factor VIII (rAHF-PFM)
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Recruiting - verified November 2011
 |
Benzocaine Clinical Trials |
